Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Journal of Medical Primatology
|
September 25, 1998
The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection
J L Heeney, M E van Gils, P van der Meide, et al.
Vaccine
|
October 1, 1989
Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120)
S W Pyle, B Morein, J W Bess, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 1998
beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques
J L Heeney, V J Teeuwsen, M van Gils, et al.
Journal of Virology
|
March 12, 1999
Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance
E J Verschoor, P Mooij, H Oostermeijer, et al.
Immunology Letters
|
April 15, 1999
HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates
J Heeney, L Akerblom, S Barnett, et al.
Nature Medicine
|
June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
A Cafaro, A Caputo, C Fracasso, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Journal of Medical Primatology
|
September 25, 1998
The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection
J L Heeney, M E van Gils, P van der Meide, et al.
Vaccine
|
October 1, 1989
Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120)
S W Pyle, B Morein, J W Bess, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 1998
beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques
J L Heeney, V J Teeuwsen, M van Gils, et al.
Journal of Virology
|
March 12, 1999
Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance
E J Verschoor, P Mooij, H Oostermeijer, et al.
Immunology Letters
|
April 15, 1999
HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates
J Heeney, L Akerblom, S Barnett, et al.
Nature Medicine
|
June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
A Cafaro, A Caputo, C Fracasso, et al.
Page
of 5